Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Longitudinal outcomes of high-risk human papillomavirus (HPV) infections as competing-risks events following cervical HPV test at baseline visit in the NIS-LAMS cohort.
Syrjänen K, Shabalova I, Sarian L, Naud P, Longatto-Filho A, Derchain S, Kozachenko V, Zakharchenko S, Roteli-Martins C, Nerovjna R, Kljukina L, Tatti S, Branovskaja M, Branca M, Grunjberga V, Erzen M, Juschenko A, Hammes LS, Podistov J, Costa S, Syrjänen S; NIS Study Research Group; LAMS Study Research Group. Syrjänen K, et al. Among authors: erzen m. Eur J Gynaecol Oncol. 2012;33(4):341-52. Eur J Gynaecol Oncol. 2012. PMID: 23091888
Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo R, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K. Sarian LO, et al. J Med Screen. 2005;12(3):142-9. doi: 10.1258/0969141054855328. J Med Screen. 2005. PMID: 16156945
Evaluation of causes of increased incidence of cervical cancer in Slovenia.
Smrkolj S, Rakar S, Mozina A, Erzen M. Smrkolj S, et al. Eur J Obstet Gynecol Reprod Biol. 2004 Dec 1;117(2):213-21. doi: 10.1016/j.ejogrb.2004.06.002. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15541860
Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study.
Sarian LO, Hammes LS, Longatto-Filho A, Guarisi R, Derchain SF, Roteli-Martins C, Naud P, Erzen M, Branca M, Tatti S, de Matos JC, Gontijo R, Maeda MY, Lima T, Costa S, Syrjänen S, Syrjänen K. Sarian LO, et al. Sex Transm Dis. 2009 Apr;36(4):241-8. doi: 10.1097/OLQ.0b013e3181935a7d. Sex Transm Dis. 2009. PMID: 19265732 Clinical Trial.
p300 expression is related to high-risk human papillomavirus infections and severity of cervical intraepithelial neoplasia but not to viral or disease outcomes in a longitudinal setting.
Syrjänen S, Naud P, Sarian L, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Arlindo F, Sakamoto-Maeda M, Costa S, Syrjänen K. Syrjänen S, et al. Int J Gynecol Pathol. 2010 Mar;29(2):135-45. doi: 10.1097/PGP.0b013e3181bccaec. Int J Gynecol Pathol. 2010. PMID: 20173499 Clinical Trial.
Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology.
Longatto-Filho A, Naud P, Derchain SF, Roteli-Martins C, Tatti S, Hammes LS, Sarian LO, Eržen M, Branca M, de Matos JC, Gontijo R, Maeda MY, Lima T, Costa S, Syrjänen S, Syrjänen K. Longatto-Filho A, et al. Among authors: erzen m. Virchows Arch. 2012 Jun;460(6):577-85. doi: 10.1007/s00428-012-1242-y. Epub 2012 May 5. Virchows Arch. 2012. PMID: 22562132 Clinical Trial.
Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CIN.
Syrjänen S, Naud P, Sarian L, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Costa S, Syrjänen K. Syrjänen S, et al. Am J Clin Pathol. 2009 Dec;132(6):883-92. doi: 10.1309/AJCPQQ07WUTZUTES. Am J Clin Pathol. 2009. PMID: 19926580
Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
Syrjänen K, Shabalova I, Naud P, Kozachenko V, Derchain S, Zakharchenko S, Roteli-Martins C, Nerovjna R, Longatto-Filho A, Kljukina L, Tatti S, Branovskaja M, Hammes LS, Branca M, Grunjberga V, Erzen M, Sarian LO, Juschenko A, Costa S, Podistov J, Syrjänen S; New Independent States of the Former Soviet Union and the Latin American Screening Study Research Groups. Syrjänen K, et al. Int J Gynecol Cancer. 2009 Jul;19(5):934-42. doi: 10.1111/IGC.0b013e3181a834fe. Int J Gynecol Cancer. 2009. PMID: 19574788 Clinical Trial.
Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix.
Erzen M, Mozina A, Bertole J, Syrjänen K. Erzen M, et al. Eur J Obstet Gynecol Reprod Biol. 2002 Mar 10;101(2):185-91. doi: 10.1016/s0301-2115(01)00524-3. Eur J Obstet Gynecol Reprod Biol. 2002. PMID: 11858896
37 results
Jump to page
Feedback